XML 33 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Acquisitions (Tables)
 6 Months Ended
Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Schedule of Business Acquisitions
The following is the purchase price for the acquisition of BioDiscovery:
Cash$52,291,000 
Estimated fair value of milestone consideration$9,000,000 
Return of cash to buyer from escrow$(694,000)
Shares of common stock issued as consideration2,723,000 
Stock price per share on closing date$5.20 
Value of estimated common stock consideration$14,159,000 
Total purchase price$74,756,000 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
The total purchase price was allocated to BioDiscovery’s tangible and identifiable intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded as goodwill, as follows:
Cash and cash equivalents$3,205,000 
Accounts receivable1,782,000 
Right-of-use assets3,987,000 
Other assets213,000 
Intangible assets26,800,000 
Goodwill49,081,000 
Accounts payable and other accrued liabilities(193,000)
Right-of-use liabilities (short-term and long-term)(3,987,000)
Deferred tax liability(5,777,000)
Contract liabilities(355,000)
Net assets acquired$74,756,000 
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination The acquisition date fair values of identifiable intangible assets acquired are as follows:
Customer relationships$3,000,000 
Developed technology22,800,000 
Tradename1,000,000 
Fair value of identifiable intangible assets$26,800,000 
Business Acquisition, Pro Forma Information The following unaudited pro forma financial information is for informational purposes only and is not necessarily indicative of the results of operations that would have been achieved as if the acquisitions had taken place as of January 1, 2020.
 Six Months Ended June 30,Three Months Ended June 30,
20212021
Revenue$9,467,000 $5,313,000 
Net loss(30,479,000)(19,320,000)
Basic and diluted net loss per share
$(0.11)$(0.07)